Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial.
Journal articles
- Letter
Akpek, EK; Karadayi, K
Published in: Am J Ophthalmol
November 1999
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Am J Ophthalmol
DOI
ISSN
0002-9394
Publication Date
November 1999
Volume
128
Issue
5
Start / End Page
662 / 663
Location
United States
Related Subject Headings
- Randomized Controlled Trials as Topic
- Postoperative Complications
- Pharmaceutical Vehicles
- Ophthalmology & Optometry
- Ophthalmic Solutions
- Ketorolac Tromethamine
- Humans
- Endophthalmitis
- Cataract Extraction
- Anti-Inflammatory Agents, Non-Steroidal
Citation
APA
Chicago
ICMJE
MLA
NLM
Akpek, E. K., & Karadayi, K. (1999). Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial. Am J Ophthalmol, 128(5), 662–663. https://doi.org/10.1016/s0002-9394(99)00333-5
Akpek, E. K., and K. Karadayi. “Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial.” Am J Ophthalmol 128, no. 5 (November 1999): 662–63. https://doi.org/10.1016/s0002-9394(99)00333-5.
Akpek EK, Karadayi K. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial. Am J Ophthalmol. 1999 Nov;128(5):662–3.
Akpek, E. K., and K. Karadayi. “Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial.” Am J Ophthalmol, vol. 128, no. 5, Nov. 1999, pp. 662–63. Pubmed, doi:10.1016/s0002-9394(99)00333-5.
Akpek EK, Karadayi K. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial. Am J Ophthalmol. 1999 Nov;128(5):662–663.
Published In
Am J Ophthalmol
DOI
ISSN
0002-9394
Publication Date
November 1999
Volume
128
Issue
5
Start / End Page
662 / 663
Location
United States
Related Subject Headings
- Randomized Controlled Trials as Topic
- Postoperative Complications
- Pharmaceutical Vehicles
- Ophthalmology & Optometry
- Ophthalmic Solutions
- Ketorolac Tromethamine
- Humans
- Endophthalmitis
- Cataract Extraction
- Anti-Inflammatory Agents, Non-Steroidal